These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6929367)
1. Usefulness of statistical models to assess the benefit of breast cancer screening: a reply. Eddy DM J Natl Cancer Inst; 1980 Jun; 64(6):1277. PubMed ID: 6929367 [No Abstract] [Full Text] [Related]
2. Usefulness of statistical models to assess the benefit of breast cancer screening. Pasternack BS; Strax P J Natl Cancer Inst; 1979 Nov; 63(5):1109-10. PubMed ID: 291744 [No Abstract] [Full Text] [Related]
3. Benefits of screening for breast cancer: application of a probabilistic model to a breast cancer detection project. Dubin N J Chronic Dis; 1979; 32(1-2):145-51. PubMed ID: 447774 [No Abstract] [Full Text] [Related]
4. [Evaluation of screening methods in the detection of breast cancer]. Semiglazov VF Vopr Onkol; 1985; 31(4):92-6. PubMed ID: 4002676 [TBL] [Abstract][Full Text] [Related]
5. The authors reply. Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA Am J Epidemiol; 2014 Oct; 180(7):760-1. PubMed ID: 25194150 [No Abstract] [Full Text] [Related]
6. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study. Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697 [TBL] [Abstract][Full Text] [Related]
8. [Theoretical value and practical applicability of mass screening for carcinoma of the breast]. De Felice C; Falqui L; Lodolini G; Luciani S; Meggiorini ML; Nusiner MP; Pozzi V Minerva Ginecol; 1984 Nov; 36(11):727-31. PubMed ID: 6527827 [No Abstract] [Full Text] [Related]
9. Identification of women at increased risk for breast cancer in a population-based screening program. Bondy ML; Vogel VG; Halabi S; Lustbader ED Cancer Epidemiol Biomarkers Prev; 1992; 1(2):143-7. PubMed ID: 1306097 [TBL] [Abstract][Full Text] [Related]
10. Regression of screening-detected breast cancer. Kalager M Lancet Oncol; 2011 Nov; 12(12):1083-4. PubMed ID: 21996167 [No Abstract] [Full Text] [Related]
11. Breast cancer screening recommendations: dynamic extrapolation of limited data. Mooney C; Merajver S Breast Cancer Res Treat; 2010 May; 121(1):143-6. PubMed ID: 20063195 [No Abstract] [Full Text] [Related]
12. Study design and statistics in the epidemiology of breast cancer. Maraqa L; Lansdown M Br J Cancer; 2006 Nov; 95(9):1301; author reply 1302-3. PubMed ID: 17024126 [No Abstract] [Full Text] [Related]
13. On the benefits and harms of screening for breast cancer. Gøtzsche PC Int J Epidemiol; 2004 Feb; 33(1):56-64; discussion 69-73. PubMed ID: 15075145 [No Abstract] [Full Text] [Related]
14. [Studies on the improvement of mass screening for breast cancer. Screening with ultrasonic diagnosis in Kagoshima Prefecture]. Hirata M Igaku Kenkyu; 1984 May; 54(5):571-88. PubMed ID: 6397953 [No Abstract] [Full Text] [Related]
16. Re: "Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial". Weiss NS Am J Epidemiol; 2014 Oct; 180(7):759-60. PubMed ID: 25194149 [No Abstract] [Full Text] [Related]
17. Selection bias in epidemiological studies of screening participants. Heuch I; Kvåle G J Chronic Dis; 1986; 39(4):323-5. PubMed ID: 3958119 [No Abstract] [Full Text] [Related]
18. Lead time estimation in a controlled screening program. Chen JS; Prorok PC Am J Epidemiol; 1983 Nov; 118(5):740-51. PubMed ID: 6638001 [TBL] [Abstract][Full Text] [Related]
19. [Breast cancer screening, European Union and France]. Tubiana M Bull Cancer; 1996 Sep; 83(9):726-31. PubMed ID: 8952647 [No Abstract] [Full Text] [Related]
20. Cancer diagnosis in a "breast clinic": a 15 years retrospection. Ghys R J Nucl Med Allied Sci; 1987; 31(4):315-20. PubMed ID: 3443882 [No Abstract] [Full Text] [Related] [Next] [New Search]